Neurogene Inc. short interest in 2021
In 2021, Neurogene Inc.'s disclosed short interest ran from 7.23% of shares outstanding on 15 Jan 2021 to 1.81% on 31 Dec 2021, a change of -5.42 percentage points. The year's high was 7.94% on 31 Mar 2021 and its low 1.74% on 15 Dec 2021, averaging 5.21% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 22.45 days on 15 Mar 2021. Full history: Neurogene Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2021 in figures
- Start of year
- 7.23% (15 Jan 2021)
- End of year
- 1.81% (31 Dec 2021)
- Change
- -5.42 pp
- High
- 7.94% (31 Mar 2021)
- Low
- 1.74% (15 Dec 2021)
- Average
- 5.21%
- Highest days to cover
- 22.45 (15 Mar 2021)
- SEC filings marked
- 8
Every report in 2021
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2021 | 7.23% | 8.24 | |
| 29 Jan 2021 | 7.13% | 14.98 | |
| 12 Feb 2021 | 7.68% | 14.69 | |
| 26 Feb 2021 | 7.11% | 16.51 | |
| 15 Mar 2021 | 7.83% | 22.45 | |
| 31 Mar 2021 | 7.94% | 11.55 | 10-K filed, results (8-K) |
| 15 Apr 2021 | 6.38% | 17.79 | |
| 30 Apr 2021 | 6.71% | 18.09 | |
| 14 May 2021 | 6.87% | 21.44 | 10-Q filed, results (8-K) |
| 28 May 2021 | 6.49% | 21.56 | |
| 15 Jun 2021 | 6.18% | 12.88 | |
| 30 Jun 2021 | 4.86% | 6.77 | |
| 15 Jul 2021 | 4.86% | 18.85 | |
| 30 Jul 2021 | 4.94% | 15.25 | |
| 13 Aug 2021 | 4.79% | 8.97 | 10-Q filed, results (8-K) |
| 31 Aug 2021 | 4.44% | 5.50 | |
| 15 Sep 2021 | 4.67% | 11.42 | |
| 30 Sep 2021 | 3.93% | 8.92 | |
| 15 Oct 2021 | 3.59% | 16.44 | |
| 29 Oct 2021 | 3.75% | 15.53 | |
| 15 Nov 2021 | 1.97% | 4.92 | 10-Q filed, results (8-K) |
| 30 Nov 2021 | 2.05% | 2.34 | |
| 15 Dec 2021 | 1.74% | 3.86 | |
| 31 Dec 2021 | 1.81% | 4.09 |
See also: Neurogene Inc.'s full history · most shorted US stocks of 2021 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.